» Articles » PMID: 35165436

Role of Bile Acids and Their Receptors in Gastrointestinal and Hepatic Pathophysiology

Overview
Specialty Gastroenterology
Date 2022 Feb 15
PMID 35165436
Authors
Affiliations
Soon will be listed here.
Abstract

Bile acids (BAs) can regulate their own metabolism and transport as well as other key aspects of metabolic homeostasis via dedicated (nuclear and G protein-coupled) receptors. Disrupted BA transport and homeostasis results in the development of cholestatic disorders and contributes to a wide range of liver diseases, including nonalcoholic fatty liver disease and hepatocellular and cholangiocellular carcinoma. Furthermore, impaired BA homeostasis can also affect the intestine, contributing to the pathogenesis of irritable bowel syndrome, inflammatory bowel disease, and colorectal and oesophageal cancer. Here, we provide a summary of the role of BAs and their disrupted homeostasis in the development of gastrointestinal and hepatic disorders and present novel insights on how targeting BA pathways might contribute to novel treatment strategies for these disorders.

Citing Articles

Primary sclerosing cholangitis.

Manns M, Bergquist A, Karlsen T, Levy C, Muir A, Ponsioen C Nat Rev Dis Primers. 2025; 11(1):17.

PMID: 40082445 DOI: 10.1038/s41572-025-00600-x.


Composition, Influencing Factors, and Effects on Host Nutrient Metabolism of Fungi in Gastrointestinal Tract of Monogastric Animals.

Deng X, Li H, Wu A, He J, Mao X, Dai Z Animals (Basel). 2025; 15(5).

PMID: 40075993 PMC: 11898470. DOI: 10.3390/ani15050710.


Targeting the ceramidase ACER3 attenuates cholestasis in mice by mitigating bile acid overload via unsaturated ceramide-mediated LXRβ signaling transduction.

Liao L, Liu Z, Liu L, Huang C, Li Y, Mao C Nat Commun. 2025; 16(1):2112.

PMID: 40025008 PMC: 11873283. DOI: 10.1038/s41467-025-57330-7.


Bi-Directional Relationship Between Bile Acids (BAs) and Gut Microbiota (GM): UDCA/TUDCA, Probiotics, and Dietary Interventions in Elderly People.

Francini E, Badillo Pazmay G, Fumarola S, Procopio A, Olivieri F, Marchegiani F Int J Mol Sci. 2025; 26(4).

PMID: 40004221 PMC: 11855466. DOI: 10.3390/ijms26041759.


Emerging role of bile acids in colorectal liver metastasis: From molecular mechanism to clinical significance (Review).

Li Z, Deng L, Cheng M, Ye X, Yang N, Fan Z Int J Oncol. 2025; 66(3).

PMID: 39981904 PMC: 11844338. DOI: 10.3892/ijo.2025.5730.


References
1.
Schaap F, Trauner M, Jansen P . Bile acid receptors as targets for drug development. Nat Rev Gastroenterol Hepatol. 2013; 11(1):55-67. DOI: 10.1038/nrgastro.2013.151. View

2.
Hofmann A . Biliary secretion and excretion in health and disease: current concepts. Ann Hepatol. 2007; 6(1):15-27. View

3.
Makishima M, Okamoto A, REPA J, Tu H, Learned R, Luk A . Identification of a nuclear receptor for bile acids. Science. 1999; 284(5418):1362-5. DOI: 10.1126/science.284.5418.1362. View

4.
Parks D, Blanchard S, Bledsoe R, Chandra G, Consler T, Kliewer S . Bile acids: natural ligands for an orphan nuclear receptor. Science. 1999; 284(5418):1365-8. DOI: 10.1126/science.284.5418.1365. View

5.
Wang H, Chen J, HOLLISTER K, Sowers L, Forman B . Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell. 1999; 3(5):543-53. DOI: 10.1016/s1097-2765(00)80348-2. View